The global burden of kidney disease and the sustainable development goals

Valerie A Luyckx, Marcello Tonelli, John W Stanifer, Valerie A Luyckx, Marcello Tonelli, John W Stanifer

Abstract

Kidney disease has been described as the most neglected chronic disease. Reliable estimates of the global burden of kidney disease require more population-based studies, but specific risks occur across the socioeconomic spectrum from poverty to affluence, from malnutrition to obesity, in agrarian to post-industrial settings, and along the life course from newborns to older people. A range of communicable and noncommunicable diseases result in renal complications and many people who have kidney disease lack access to care. The causes, consequences and costs of kidney diseases have implications for public health policy in all countries. The risks of kidney disease are also influenced by ethnicity, gender, location and lifestyle. Increasing economic and health disparities, migration, demographic transition, unsafe working conditions and environmental threats, natural disasters and pollution may thwart attempts to reduce the morbidity and mortality from kidney disease. A multisectoral approach is needed to tackle the global burden of kidney disease. The sustainable development goals (SDGs) emphasize the importance of a multisectoral approach to health. We map the actions towards achieving all of the SDGs that have the potential to improve understanding, measurement, prevention and treatment of kidney disease in all age groups. These actions can also foster treatment innovations and reduce the burden of such disease in future generations.

References

    1. Resolution A/RES/70/1. Transforming our world: the 2030 agenda for sustainable development. In: Seventieth United Nations General Assembly, New York, 25 September 2015. New York: United Nations; 2015. Available from: [cited 2018 Mar 2].
    1. Global action plan for the prevention and control of noncommunicable diseases 2013-2020. Geneva, Switzerland: World Health Organization; 2013. Available from: [cited 2017 Apr 20].
    1. 2008-2013 action plan for the global strategy for the prevention and control of noncommunicable diseases. Geneva: World Health Organization; 2009. Available from: [cited 2017 Apr 20].
    1. Pearce N, Ebrahim S, McKee M, Lamptey P, Barreto ML, Matheson D, et al. Global prevention and control of NCDs: limitations of the standard approach. J Public Health Policy. 2015. November;36(4):408–25. 10.1057/jphp.2015.29
    1. Levin A, Tonelli M, Bonventre J, Coresh J, Donner JA, Fogo AB, et al.; ISN Global Kidney Health Summit participants. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017. October 21;390(10105):1888–917. 10.1016/S0140-6736(17)30788-2
    1. Kassebaum NJ, Arora M, Barber RM, Bhutta ZA, Brown J, Carter A, et al.; GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016. October 8;388(10053):1603–58. 10.1016/S0140-6736(16)31460-X
    1. Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al.; GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016. October 8;388(10053):1459–544. 10.1016/S0140-6736(16)31012-1
    1. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015. May 16;385(9981):1975–82. 10.1016/S0140-6736(14)61601-9
    1. Mehta RL, Cerdá J, Burdmann EA, Tonelli M, García-García G, Jha V, et al. International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet. 2015. June 27;385(9987):2616–43. 10.1016/S0140-6736(15)60126-X
    1. Noncommunicable diseases. Fact sheet [internet]. Geneva: World Health Organization; 2017. Available from: [cited 2018 Mar 20].
    1. Global status report on noncommunicable diseases 2014. Geneva: World Health Organization; 2014. Available from: [cited 2017 April 20].
    1. Murray CJ, Barber RM, Foreman KJ, Abbasoglu Ozgoren A, Abd-Allah F, Abera SF, et al.; GBD 2013 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet. 2015. November 28;386(10009):2145–91. 10.1016/S0140-6736(15)61340-X
    1. Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, et al.; GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017. September 16;390(10100):1151–210. 10.1016/S0140-6736(17)32152-9
    1. Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011. December;80(12):1258–70. 10.1038/ki.2011.368
    1. Chapter 9: healthcare expenditures for persons with ESRD [internet]. Ann Arbor: United States Renal Data System; 2017. Available from: [cited 2018 Mar 22].
    1. Tonelli M, Muntner P, Lloyd A, Manns BJ, Klarenbach S, Pannu N, et al.; Alberta Kidney Disease Network. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet. 2012. September 1;380(9844):807–14. 10.1016/S0140-6736(12)60572-8
    1. Luyckx VA, Tuttle KR, Garcia Garcia G, Benghanem Gharbi M, Heerspink HJ, Johnson DW, et al. Reducing major risk factors for chronic kidney disease. Kidney Int Suppl. 2017;7(2):71–87. 10.1016/j.kisu.2017.07.003
    1. Tackling NCDs. ‘Best buys’ and other recommended interventions for the prevention and control of noncommunicable diseases. Geneva: World Health Organization; 2017. Available from: [cited 2018 Feb 27].
    1. Health in all policies: Helsinki statement. Framework for country action. Geneva: World Health Organization; 2014. Available from: [cited 2016 Aug 31].
    1. Norton JM, Moxey-Mims MM, Eggers PW, Narva AS, Star RA, Kimmel PL, et al. Social determinants of racial disparities in CKD. J Am Soc Nephrol. 2016. September;27(9):2576–95.
    1. Kishore SP, Vedanthan R, Fuster V. Promoting global cardiovascular health ensuring access to essential cardiovascular medicines in low- and middle-income countries. J Am Coll Cardiol. 2011. May 17;57(20):1980–7. 10.1016/j.jacc.2010.12.029
    1. Olowu WA, Niang A, Osafo C, Ashuntantang G, Arogundade FA, Porter J, et al. Outcomes of acute kidney injury in children and adults in sub-Saharan Africa: a systematic review. Lancet Glob Health. 2016. April;4(4):e242–50. 10.1016/S2214-109X(15)00322-8
    1. Jha V. Current status of end-stage renal disease care in India and Pakistan. Kidney Int Suppl. 2013;3(2):157–60. 10.1038/kisup.2013.3
    1. Moosa MR, Maree JD, Chirehwa MT, Benatar SR. Use of the ‘Accountability for reasonableness’ approach to improve fairness in accessing dialysis in a middle-income country. PLoS One. 2016. October 4;11(10):e0164201. 10.1371/journal.pone.0164201
    1. McIntyre D, McKee M, Balabanova D, Atim C, Reddy KS, Patcharanarumol W; 250 signatories, a full list of signatories is available in the appendix. Open letter on the SDGs: a robust measure for universal health coverage is essential. Lancet. 2016. December 10;388(10062):2871–2. 10.1016/S0140-6736(16)32189-4
    1. Low Birth Weight and Nephron Number Working Group. The impact of kidney development on the life course: a consensus document for action. Nephron. 2017;136(1):3–49. 10.1159/000457967
    1. Freudenberg N. Healthy-food procurement: using the public plate to reduce food insecurity and diet-related diseases. Lancet Diabetes Endocrinol. 2016. May;4(5):383–4. 10.1016/S2213-8587(16)00078-4
    1. Colchero MA, Rivera-Dommarco J, Popkin BM, Ng SW. In Mexico, Evidence of sustained consumer response two years after implementing a sugar-sweetened beverage tax. Health Aff (Millwood). 2017. March 1;36(3):564–71. 10.1377/hlthaff.2016.1231
    1. Bello AK, Levin A, Tonelli M, Okpechi IG, Feehally J, Harris D, et al. ISN Global Kidney Health Atlas. Brussels: International Society of Nephrology; 2017. Available from: [cited 2018 Mar 30].
    1. Cobo G, Hecking M, Port FK, Exner I, Lindholm B, Stenvinkel P, et al. Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis. Clin Sci (Lond). 2016. July 1;130(14):1147–63. 10.1042/CS20160047
    1. Harnessing the power of data for girls. taking stock and looking ahead to 2030. New York: United Nations Children’s Fund; 2016. Available from: [cited 2018 Mar 30].
    1. Beydoun MA, Poggi-Burke A, Zonderman AB, Rostant OS, Evans MK, Crews DC. Perceived discrimination and longitudinal change in kidney function among urban adults. Psychosom Med. 2017. September;79(7):824–34. 10.1097/PSY.0000000000000478
    1. Lack of sanitation for 2.4 billion people is undermining health improvements. Final MDG progress report on water and sanitation released [internet]. Geneva: World Health Organization; 2015. Available from: [cited 2017 Jul 3].
    1. Stanifer JW, Muiru A, Jafar TH, Patel UD. Chronic kidney disease in low- and middle-income countries. Nephrol Dial Transplant. 2016. June;31(6):868–74. 10.1093/ndt/gfv466
    1. Overbo A, Williams AR, Evans B, Hunter PR, Bartram J. On-plot drinking water supplies and health: a systematic review. Int J Hyg Environ Health. 2016. July;219(4-5):317–30. 10.1016/j.ijheh.2016.04.008
    1. Lunyera J, Mohottige D, Von Isenburg M, Jeuland M, Patel UD, Stanifer JW. CKD of uncertain etiology: a systematic review. Clin J Am Soc Nephrol. 2016. March 7;11(3):379–85. 10.2215/CJN.07500715
    1. Johnson RJ, Stenvinkel P, Jensen T, Lanaspa MA, Roncal C, Song Z, et al. Metabolic and kidney diseases in the setting of climate change, water shortage, and survival factors. J Am Soc Nephrol. 2016. August;27(8):2247–56. 10.1681/ASN.2015121314
    1. Vonesch N, D’Ovidio MC, Melis P, Remoli ME, Ciufolini MG, Tomao P. Climate change, vector-borne diseases and working population. Ann Ist Super Sanita. 2016. Jul-Sep;52(3):397–405. Epub20161005.
    1. Agar JW. Green dialysis: the environmental challenges ahead. Semin Dial. 2015. Mar-Apr;28(2):186–92. 10.1111/sdi.12324
    1. Muralidharan A, White S. The need for kidney transplantation in low- and middle-income countries in 2012: an epidemiological perspective. Transplantation. 2015. March;99(3):476–81. 10.1097/TP.0000000000000657
    1. Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, Kelly TN, et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015. November;88(5):950–7. 10.1038/ki.2015.230
    1. Giles-Corti B, Vernez-Moudon A, Reis R, Turrell G, Dannenberg AL, Badland H, et al. City planning and population health: a global challenge. Lancet. 2016. December 10;388(10062):2912–24. 10.1016/S0140-6736(16)30066-6
    1. Kickbusch I, Allen L, Franz C. The commercial determinants of health. Lancet Glob Health. 2016. December;4(12):e895–6. 10.1016/S2214-109X(16)30217-0
    1. Yusuf S, Attaran A, Bosch J, Joseph P, Lonn E, McCready T, et al.; Working Group on the Summit on Combination Therapy for CVD. Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges. Eur Heart J. 2014. February;35(6):353–64. 10.1093/eurheartj/eht407
    1. McPhee M, Arumainayagam N, Clark M, Burfitt N, DasGupta R. Renal injury management in an urban trauma centre and implications for urological training. Ann R Coll Surg Engl. 2015. April;97(3):194–7. 10.1308/003588414X14055925061117
    1. Sever MS, Vanholder R, Ashkenazi I, Becker G, Better O, Covic A, et al.; RDRTF of ISN Work Group on Recommendations for the Management of Crush Victims in Mass Disasters. Recommendation for the management of crush victims in mass disasters. Nephrol Dial Transplant. 2012. April;27 Suppl 1:i1–67. 10.1093/ndt/gfs156
    1. Isreb M, Alyousef M, Obaid N, Abbara A, Sekkarie M. Effect of besiegement on non-communicable diseases: haemodialysis. Lancet. 2016. November 12;388(10058):2350. 10.1016/S0140-6736(16)32129-8
    1. Cervantes L, Fischer S, Berlinger N, Zabalaga M, Camacho C, Linas S, et al. The illness experience of undocumented immigrants with end-stage renal disease. JAMA Intern Med. 2017. April 1;177(4):529–35. 10.1001/jamainternmed.2016.8865
    1. Stewart IJ, Sosnov JA, Howard JT, Orman JA, Fang R, Morrow BD, et al. Retrospective analysis of long-term outcomes after combat injury: a hidden cost of war. Circulation. 2015. December 1;132(22):2126–33. 10.1161/CIRCULATIONAHA.115.016950
    1. Nowotny KM, Rogers RG, Boardman JD. Racial disparities in health conditions among prisoners compared with the general population. SSM Popul Health. 2017. December;3(3):487–96. 10.1016/j.ssmph.2017.05.011
    1. A/72/662. Progress on the prevention and control of non-communicable diseases. Report of the Secretary-General. In: Seventy-second United Nations General Assembly, New York, 21 December 2015. New York: United Nations; 2015. Available from: [cited 2018 Mar 2].

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi